Article Sidebar

Submitted
Apr 1, 2021
Published
Apr 1, 2021
Download
PDF
Statistic
Read Counter : 83 Download : 51

Main Article Content

Abstract

Introduction


Urinary tract infection (UTI) is one of the most common infections in outpatients setting as well as in acute and long term care hospital patients. Successful treatment and prevention of recurrence of UTI require bacteriological identification, its sensitivity to antimicrobials, selection of appropriate antimicrobials and their appropriate application.


Methodology


In present study 212 patients have been included from Medicine, Surgery and Obstetrics & Gynaecology Department over one year period.


Result


Each patient have been given on an average 1.68 ± 0.77 and 0.86 ± 1.04 medicines by branded and generic names. Fluoroquinolones were the most commonly used antibacterials followed by cephalosporins. 47.13% medicines were listed in the 19th model list of essential medicines (WHO, 2015). 89.64% medicines prescribed rationally. All 541 (100%) medicine uses were found to be appropriate or most appropriate.


Conclusion


Fluoroquinolones and cephalosporins were the most commonly prescribed antibiotics. The need to adhere to standard treatment guidelines and prescribing from the essential drug list, using generic names have to be impressed upon treating physicians.

Keywords

Urinary tract infection Drug Utilization Antimicrobials

Article Details

How to Cite
Rushika S. Modi, & Sagun V. Desai. (2021). Drug utilization study in urinary tract infection in a tertiary care hospital: a prospective study. International Journal of Research in Pharmacology & Pharmacotherapeutics, 8(1), 82-86. https://doi.org/10.61096/ijrpp.v8.iss1.2019.82-86
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1]. Pallett A, Hand K. Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria. Journal of Antimicrobial Chemotherapy. 65(3), 2010, 25-33.
  2. [2]. Truter I. A Review of Drug Utilization Studies and Methodologies. Jordan Journal of Pharmaceutical Sciences. 1(2), 2008, 91-104.
  3. [3]. Al-Badr A, Al-Shaikh G. Recurrent urinary tract infections management in women: a review. Sultan Qaboos University Medical Journal. 13(3), 2013, 359.
  4. [4]. Tan CW, Chlebicki MP. Urinary tract infections in adults. 57(9), 2016, 485.
  5. [5]. Nathiaya D, Pandey K, Sharma RK. A Study on Drug Utilization Pattern of Antimicrobials in outpatient departments of Medicine at Tertiary Care Hospital. Int. J. Res Pharm Sci 4(2), 2014, 40-45.
  6. [6]. Fourcroy JL, Berner B, Chiang YK, Cramer M, Rowe L, Shore N. Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women. Antimicrobial agents and chemotherapy. 49(10), 2005, 4137-43.
  7. [7]. Pandey D.K., Hardeep, Rauf M.J., Kumar R, Mohd F.M. Drug Utilization Pattern in Urinary Tract Infections: A retrospective Study. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 3(4), 2012, 1231-1235.
  8. [8]. Chowta M.N. Drug Utilization Pattern in Urinary Tract Infections: A Retrospective Study. Instasci Journal of Medical Sciences and Clinical Research. 2011, 1(1).
  9. [9]. Laurence DR in editor, D.N.Bennett and Brown MJ. Clinical pharmacology, Elsevier publication Newyork, Unwanted effects and adverse drug reaction. Clinical pharmacology 9, 135-136.
  10. [10]. Behzadi P, Behzadi E, Yazdanbod H, Aghapour R, Cheshmeh MA, Omran DS. Urinary tract infections associated with Candida albicans. Maedica. 5(4), 2010, 277.
  11. [11]. Ladipo OA. Nutrition in pregnancy: mineral and vitamin supplements. The American journal of clinical nutrition. 72(1), 2000, 280S-90S.
  12. [12]. Kronenberg A, Bütikofer L, Odutayo A, Mühlemann K, da Costa BR, Battaglia M, Meli DN, Frey P, Limacher A, Reichenbach S, Jüni P. Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial. bmj. 8, 2017, 359-4784.
  13. [13]. Brunton L L, Chabner B A, Knollmann B C. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. McGraw-Hill Companies, Inc. United States of America, 12, 2011, 959-993.
  14. [14]. Kshirsagar NA. Rational use of medicines: cost consideration & way forward. The Indian journal of medical research. 144(4), 2016, 502.
  15. [15]. Dalal K, Ganguly B, Gor A. Assessment of rationality of fixed dose combinations approved in CDSCO list. Journal of clinical and diagnostic research: JCDR. 10(4), 2016, FC05.